Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-12-000235
Filing Date
2012-03-12
Accepted
2012-03-12 14:17:50
Documents
3
Period of Report
2012-03-12

Document Format Files

Seq Description Document Type Size
1 tekmira6k_03122012.htm 6-K 15451
2 MATERIAL CHANGE REPORT DATED MARCH 6, 2012 ex99_1.htm EX-99.1 37051
3 tekmira_logo.jpg GRAPHIC 8366
  Complete submission text file 0000912282-12-000235.txt   65217
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 12683515
SIC: 2834 Pharmaceutical Preparations